New Therapeutic System of Unruptured Intracranial Aneurysms Based on Big Data From Chinese Population (NATIONAL-1)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
This is a prospective, multicenter, observational study, aiming at comparing the Safety and effectiveness among the different surgical treatment of unruptured intracranial aneurysms in China, so as to improve the diagnosis and treatment of unruptured intracranial aneurysms.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients diagnosed with unruptured intracranial saccular aneurysm at all age.
patients diagnosed with unruptured intracranial saccular aneurysm on CTA, MRA or DSA.
patients willing to participate in this clinical trial and attach to regular follow up.
intracranial aneurysm correlating to AVM.
intracranial non-saccular aneurysm.
the rupture or unrpture of the aneurysm confirmed on CTA、MRA or DSA.
patients unwilling to participate in this clinical trial and attach to regular follow up.